Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C

Antimicrobial Agents and Chemotherapy
Chris MelloGabriel Birkus

Abstract

Human rhinovirus type C (HRV-C) is a newly discovered enterovirus species frequently associated with exacerbation of asthma and other acute respiratory conditions. Until recently, HRV-C could not be propagated in vitro, hampering in-depth characterization of the virus replication cycle and preventing efficient testing of antiviral agents. Herein we describe several subgenomic RNA replicon systems and a cell culture infectious model for HRV-C that can be used for antiviral screening. The replicon constructs consist of genome sequences from HRVc15, HRVc11, HRVc24, and HRVc25 strains, with the P1 capsid region replaced by a Renilla luciferase coding sequence. Following transfection of the replicon RNA into HeLa cells, the constructs produced time-dependent increases in luciferase signal that can be inhibited in a dose-dependent manner by known inhibitors of HRV replication, including the 3C protease inhibitor rupintrivir, the nucleoside analog inhibitor MK-0608, and the phosphatidylinositol 4-kinase IIIβ (PI4K-IIIβ) kinase inhibitor PIK93. Furthermore, with the exception of pleconaril and pirodavir, the other tested classes of HRV inhibitors blocked the replication of full-length HRVc15 and HRVc11 in human airway epithelial cells ...Continue Reading

Citations

Nov 14, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bradley J Gardiner, David R Snydman
Jul 18, 2015·Experimental Cell Research·Evzen Boura, Radim Nencka
Feb 18, 2016·Journal of Medicinal Chemistry·Florentine U RutaganiraJohn E Burke
Apr 4, 2016·La Presse médicale·L GuilleminaultR Epaud
May 13, 2017·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Kelvin K W ToKwok-Yung Yuen
Apr 8, 2018·Nature Reviews. Microbiology·Jim BaggenFrank J M van Kuppeveld
Oct 2, 2019·Physical Chemistry Chemical Physics : PCCP·Shuaizhen TianTong Zhu
Nov 7, 2019·Microorganisms·Cristian-Marian PopescuMihnea Zdrenghea
Mar 23, 2018·Antiviral Chemistry & Chemotherapy·Paul C JordanJerome Deval
Jun 6, 2020·Expert Review of Respiratory Medicine·John CafferkeyPatrick Mallia
Jul 31, 2020·Clinical and Experimental Medicine·Matheus Pelinski da SilveiraDébora Tavares de Resende E Silva
Jun 15, 2019·Viruses·Silvia VandiniMarcello Lanari
Jun 20, 2019·Journal of Biomedical Science·Collins Oduor Owino, Justin Jang Hann Chu
Sep 25, 2018·Future Virology·Victor CasanovaPeter G Barlow
Jul 5, 2021·European Journal of Pharmacology·Yan-Ping LiMing Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.